Binocularity stimulating treatment in patients with amblyopia
- Conditions
- Diseases of the eye and adnexa
- Registration Number
- KCT0005150
- Lead Sponsor
- Jeonbuk National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- All
- Target Recruitment
- 38
i. Subjects with residual amblyopia defined as no more vision improvement following patching for at least 6 months at Chonbuk National University Hospital in South Korea.
ii. When both the study subject and the representative of the study have received sufficient explanation (test process, possible side effects, etc.) to understand this and voluntarily agree to participate in the study.
A. Subjects diagnosed with systemic diseases such as congenital brain disease
B. Subjects too young to test or understand the contents
C. Subjects with other ophthalmic diseases (cataract, glaucoma, congenital optic nerve disease, etc.) that may affect vision or binocular function
D. Subjects with a history of eye trauma
E. Subjects with chronic neurological symptoms, such as headache and dizziness
F. In addition to the above, if it is determined that the clinical research is difficult due to the judgment of the person in charge of the clinical research
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visual acuity
- Secondary Outcome Measures
Name Time Method Stereopsis
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.